⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

VTRS · Viatris Inc.

$17.64 latest stored close
Detected setup Cup & Handle

Watch · Quality 22/100

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about VTRS

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Health Technology / VTRS

$VTRS

Viatris Inc.

Viatris Inc. is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $21B.

Strong Buy · 100 Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 2 Data 1h 58m ago
$17.64 latest close
← Back Join to Watchlist $VTRS Share card
Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Review six verdicts Inspect chart
Earnings-risk mode

Normal technical setup

Thursday, August 6, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

VTRS+2.32%
Sector proxy · XLV+0.51%
Broad market · SPY+0.02%
Same completed session window ending 2026-07-27. VTRS was +1.81 points vs XLV. +2.30 points vs SPY. Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $17.64 Jul 27 close
52W High $17.75 -0.6%
52W Low $8.62
Wks Since High 0w
Base B2
SMA 50 $16.39
SMA 200 $13.79
Avg Vol 9,798,819
RS Rank 92
RS vs High +0.0%
RS Slope +9.0% ▲
Grp Rank #16/64
ADR% 2.9%
ATR(14) $0.53 (3.0%)
Rel Vol (today) 1.00×
Vol Pace N/A
U/D Vol 0.99
A/D Days 18A / 12D
A/D Rating A+
VDU Bars 0/10 d
Power Trend 18d
Earnings 9d
$8.62
$17.75 99%

VTRS Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for VTRS.

Create Free Account
Setup Quality A 6/7 signals
Jul 24: 65 (Cup & Handle)Jul 27: 65 (Cup & Handle)Jul 28: 65 (Cup & Handle)65 Score trend
✓ Stage 2 · Advancing ✓ Power Trend 18d ✓ RS New High ✓ Trend 8/8 ✗ No Pattern ✓ CANSLIM 73.1 (B) ✓ Gatekeeper Base #2 (B)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$VTRS · $17.64 · as of 2026-07-27 · multi-factor read
100
/ 100
Strong Buy

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$16.39 ↑
100-day$15.38 ↑
200-day$13.79 ↑
Bullish (50 > 200)

RSI (14)

Reading62.3 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+0.065

Bullish — MACD above its signal line and above zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width92% · 12.1%

Near the upper band — buyers in control.

Volume · Buyer vs Seller

Up/Down vol0.99 · Neutral
Rel volume1.0×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $17.7552-week high
Price · $17.64now
S · $15.98swing level
S · $15.50swing level
S · $14.94swing level

Fibonacci · Uptrend swing

23.6%$16.60
38.2%$15.89
50.0%$15.31
61.8%$14.73
78.6%$13.91

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for VTRS — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 90 (leader)
Want this read in a legend's voice? 💬 Ask a Legend about VTRS
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Minervini
Watch
Minervini B

Trend-template read: 9/12 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $17.64, MA150 $14.85, MA200 $13.79
1.2 150-day MA > 200-day MAMA150 $14.85 vs MA200 $13.79
Failing evidence
2. Quarterly EPS growth ≥ 25%+3.5% QoQ
2. ROE ≥ 17%ROE -2.0%
9/12 checks
Method → Playbook → Ask →
O'Neil
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 90
N: Near 52-week high or RS line new high0.6% below high | RS line new high: True
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+3.5% QoQ
A: Annual earnings & revenue qualityRev -3.0% | ROE -2.0%
3/8 checks
Method → Playbook → Ask →
Weinstein
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $17.64 vs MA200 $13.79
Failing evidence
Volume expansion above averageVolume ratio 1.00x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Method → Playbook → Ask →
Livermore
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$17.64
Relative strengthRS 90
Failing evidence
Volume vs average1.00x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Darvas
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$17.64
Relative strengthRS 90
Failing evidence
Volume vs average1.00x
Box top broken on heavy volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Wyckoff
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$17.64
Relative strengthRS 90
Failing evidence
Volume vs average1.00x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Method → Playbook → Ask →
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Follow-Through Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH NH
NH164RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +3 A+
A: 18 D: 15 Net: +365 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 4/7 met
B 4/7 SEPA
Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ +4%
✗ Revenue growth ≥20% YoY -3%
✓ Gross margin ≥30% 40%
✗ ROE ≥17% -2%
✓ RS rating ≥80 (leadership) 90
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -0.6%

Method Playbook

📋 Trade it like Weinstein EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
Weinstein C · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Cup & Handle ⚠ Rising wedge ⚠ Negative earnings (CANSLIM C fail)
65.0 score
RS Score 90
Trend 8/8 ✓
CANSLIM 73.1* (B)
21.2% cup depth 9.2% handle
Why This Setup?
Cup & Handle

depth=21.2%, handle_pb=9.2%, lips_diff=7.3%, upper_half=yes, u_shape=yes, near_pivot=yes, orderly=yes | Strong trend (8/8) | Top RS (90) | High-confidence pattern (82%) | RS at new high | Power Trend | Stage 2 | Readiness 88/100 (approaching) | CANSLIM 73.1 (B) | ⚠ Rising wedge; Negative earnings (CANSLIM C fail)

Ask a Legend ▾
The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

2/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

8/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $17.64 vs SMA150 $14.85 / SMA200 $13.79
SMA 150 above SMA 200 SMA150 $14.85 vs SMA200 $13.79
SMA 200 trending up Slope +0.69 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $16.39
Price above SMA 50 $17.64 vs SMA50 $16.39
30%+ above 52W low +104.6% from $8.62
Within 25% of 52W high -0.6% from $17.75
RS score above 70 RS 90

Fundamentals

52W Range
99%
Mkt Cap SEC
20.5B
EPS QoQ
+4%
Rev YoY
-3%
ROE
-2%
Gross Margin
40%
D/E
0.98
EPS TTM
$-3.00
Float
1.2B
Insider
No Buy

Company

Legend AI snapshot
Viatris Inc.
VTRS · NASDAQ · Health Technology · Pharmaceuticals: Major
$17.64latest close $20.5Bmarket cap 92RS rank 65setup score
Track all markets on TradingView
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 73.1* CANSLIM * disqualified on C, M
C · Curr. EPS
40
A · Annual EPS
52
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
90
I · Inst. Spons.
96
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
100
W. Support
$12.87
W. Resist
$17.67
Weekly Structure

Scan History

20× streak
Jul 24: 65 (Cup & Handle)Jul 27: 65 (Cup & Handle)Jul 28: 65 (Cup & Handle)65
Jul 28
Cup & Handle ✓ Gate
65
Jul 27
Cup & Handle ✓ Gate
65 0.0%
Jul 24
Cup & Handle ✓ Gate
65 +2.3%

Get the full picture on VTRS

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial